At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran ...
Keytruda is an immunotherapy drug that is prescribed to cancer patients and is used to treat different types of cancer. It was first approved by the FDA in 2014 for the treatment of advanced or ...
This synergistic rationale drove the two-part structure of Toragen’s Phase 1 trial, with monotherapy in Part 1 and ...
Dallas and Austin are part of a worldwide clinical trial underway to find a more effective treatment to lower the recurrence of melanoma or high-risk skin cancer. It involves a highly advertised drug ...
BioInvent International (STO:BINV)24% confirmed ORR (including complete response) in heavily pretreated patients (n=25) with advanced ovarian cancer who received BI-1808 and KEYTRUDA - multiplying by ...
GlobalData on MSN
MSD and Adcendo sign collaboration agreement for Phase Ib trial
Adcendo will sponsor the Phase Ib clinical trial, and MSD will provide pembrolizumab.
EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results